. Overview Pyxis Oncology is a clinical-stage oncology company advancing a development strategy focused on addressing unmet medical needs in patients with solid tumors with an immediate focus on head and neck squamous cell carcinoma (HNSCC). Our lead product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational novel antibody-drug conjugate (ADC) that uniquely targets the splice variant of fibronectin, extradomain-B of fibronectin (EDB+FN), a non-cellular structural c...
Q2 FY2026 — expected 2026-08-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-23 | 2025-12-31 | 0001193125-26-118532 | EDGAR | 96K words |
| 2025-03-18 | 2024-12-31 | 0000950170-25-040771 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0000950170-24-034868 | EDGAR | — |
| 2023-03-22 | 2022-12-31 | 0000950170-23-009046 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0000950170-22-004850 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001193125-26-347913 | EDGAR | — |
| 2025-11-03 | 2025-09-30 | 0001193125-25-261696 | EDGAR | 55K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108906 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-071996 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124602 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097073 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059099 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060354 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041605 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-020836 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0000950170-22-020701 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017222 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-13 | 0001193125-26-347911 | EDGAR | — |
| 2026-03-23 | 0001193125-26-118525 | EDGAR | 4K words |
| 2026-02-06 | 0001193125-26-041169 | EDGAR | — |
| 2025-12-18 | 0001193125-25-323704 | EDGAR | — |
| 2025-11-03 | 0001193125-25-261689 | EDGAR | — |
| 2025-08-14 | 0000950170-25-108898 | EDGAR | — |
| 2025-08-04 | 0000950170-25-101618 | EDGAR | — |
| 2025-07-03 | 0000950170-25-093456 | EDGAR | — |
| 2025-06-18 | 0000950170-25-087907 | EDGAR | — |
| 2025-05-15 | 0000950170-25-071992 | EDGAR | — |
83 total filings indexed. 56 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001782223 |
| Ticker | PYXS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.pyxisoncology.com |
| Listed | 2021-10-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PYXS (~200 tokens, structured JSON with cryptographic provenance)